Lower Beclin 1 downregulates HER2 expression to enhance tamoxifen sensitivity and predicts a favorable outcome for ER positive breast cancer | |
Gu, Yu; Chen, Tianxiang; Li, Guangliang; Xu, Cong; Xu, Zhenzhen; Zhang, Jing; He, Kuifeng; Zheng, Linyan; Guan, Zhonghai; Su, Xinyun | |
刊名 | ONCOTARGET |
2017 | |
卷号 | 8期号:32 |
关键词 | breast cancer tamoxifen resistance prognosis beclin 1 HER2 |
ISSN号 | 1949-2553 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3620852 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Gu, Yu,Chen, Tianxiang,Li, Guangliang,et al. Lower Beclin 1 downregulates HER2 expression to enhance tamoxifen sensitivity and predicts a favorable outcome for ER positive breast cancer[J]. ONCOTARGET,2017,8(32). |
APA | Gu, Yu.,Chen, Tianxiang.,Li, Guangliang.,Xu, Cong.,Xu, Zhenzhen.,...&Teng, Lisong.(2017).Lower Beclin 1 downregulates HER2 expression to enhance tamoxifen sensitivity and predicts a favorable outcome for ER positive breast cancer.ONCOTARGET,8(32). |
MLA | Gu, Yu,et al."Lower Beclin 1 downregulates HER2 expression to enhance tamoxifen sensitivity and predicts a favorable outcome for ER positive breast cancer".ONCOTARGET 8.32(2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论